China-Italy Pharmaceutical Conference, 3-4.11, Hangzhou

The Hangzhou Investment Promotion Bureau, in collaboration with Livolsi & Partners and the Italian Chamber of Commerce in China (CCIC), is pleased to invite you to the upcoming Italy-China Cooperation Initiative, dedicated to the development of new business opportunities for the pharmaceutical industry of the future. The event will take place on November 3–4, 2026, in Hangzhou, Zhejiang Province, bringing together Italian and Chinese bio-pharmaceutical companies, institutions and industry stakeholders.

WHY PARTICIPATE?

The initiative offers a valuable opportunity to explore concrete future prospects for industrial and commercial cooperation between Italy and China in the bio-pharmaceutical sector. Participants will have the opportunity to identify potential partnerships, exchange expertise and explore opportunities related to technology transfer, investment, R&D, supply chains and market access. The programme is designed to foster collaboration and create new synergies that can support business development in China, Italy and international markets.

The event will take place over two days: the first features institutional and business representatives while the second day will focus on company visits in Hangzhou and B2B meetings.

AGENDA​

November 3rd - Institutional Event

15:00–15:10 Welcome remarks by the Municipal Government of Hangzhou

15:10–15:20 Institutional greetings

15:20–15:35 Investment opportunities in Hangzhou’s bio-pharmaceutical sector

15:35–15:50 Overview of the Italian pharmaceutical market and key requirements for Italy-China cooperation by Alberto Conforti,  Head of  International Development at Livolsi&Partners

15:50–16:00 Presentation of the CCIC Healthcare Working Group by Elena Barboni, BD Director of Flamma S.p.A. and Coordinator of CCIC HCWG

16:00–16:10 Italy-China cooperation in APIs by Pierfrancesco Morosini, President at  Aschimfarma (online)

16:10–16:30 Keyno te Presentation The Integration of Innovation between Multinational Corporations and China by Boston Consulting Group

16:30–16:40 Italian company case study by Yu Jintao, General Manager of Copan Medical Shanghai Co.

16:40–17:00 IT+BT integration and AI-enabled new drug development by Cao Ji, Professor at the College of Pharmaceutical Sciences, Zhejiang University and Executive Vice Director of Zhejiang University Institute of Intelligent Innovative Pharmaceuticals. As a National Ten-Thousand Talents Young Top-Notch Talen.

17:00–17:10 Case study on internationalization projects by Tigermed

17:10–17:20 Financial services supporting cooperation projects by Bank of Communications Zhejiang Branch

17:20–17:30 Aschimfarma MOU signing ceremony

17:30–19:00 Institutional welcome dinner

19:30 Light show at the Urban Balcony

November 4th - B2B Meetings & Company Visits

09:30–10:30 Visit to Hangzhou Biopharma Town and visit Hangzhou Institute of Medicine Chinese Academy of Sciences

10:30-11:00 Chi nese Enterprise Investment Institution Sharing by HeDa Fund

11:00-11:30 Italian enterprise representatives share their experiences (2-3 companies)

11:30–12:00 Targeted B2B meetings between Italian and Hangzhou-based companies

12:00–13:30 Business lunch

14:00–16:00 Visits to leading bio-pharmaceutical companies in Hangzhou: Betta pharma

16:00 Closing remarks and departure arrangements

​

The event is open only to CCIC Members and pharmaceutical and medical devices companies. The confirmation is subject to prior approval.

The participation is free of charge, and it includes accommodation and meals in Hangzhou.

For more information contact us at: w.chen@cameraitacina.com